A Feasibility Study to Evaluate the Performance of the Harmony 1 Sensors in Adults and Pediatrics
Not Applicable
Withdrawn
- Conditions
- Type 1 Diabetes
- Registration Number
- NCT02646878
- Lead Sponsor
- Medtronic Diabetes
- Brief Summary
The purpose of this study is to demonstrate the performance of the Harmony 1 Sensor in subjects age 14 - 75 years.
- Detailed Description
The study is a multi-center, prospective single-sample correlational design without controls.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Subject is 14 - 75 years of age at time of screening
- A clinical diagnosis of type 1 or 2 diabetes for a minimum of 6 months duration as determined via medical record or source documentation by an individual qualified to make a medical diagnosis
- Adequate venous access as assessed by investigator or appropriate staff
Exclusion Criteria
- Subject will not tolerate tape adhesive in the area of Harmony 1 Sensor placement as assessed by qualified individual.
- Subject has any unresolved adverse skin condition in the area of Harmony 1 Sensor or device placement (e.g., psoriasis, rash, Staphylococcus infection)
- Subject is actively participating in an investigational study (drug or device) wherein they have received treatment from an investigational study (drug or device) in the last 2 weeks
- Subject is female and has a positive pregnancy screening test
- Females of child bearing age and who are sexually active should be excluded if they are not using a form of contraception deemed reliable by investigator
- Subject is female and plans to become pregnant during the course of the study
- Subject has had a hypoglycemic seizure within the past 6 months
- Subject has had hypoglycemia resulting in loss of consciousness within the past 6 months prior to screening visit.
- Subject has had an episode of diabetic ketoacidosis (DKA) within the past 6 months prior to screening visit.
- Subject has a history of a seizure disorder
- Subject has central nervous system or cardiac disorder resulting in syncope
- Subject has a history of myocardial infarction, unstable angina, coronary artery bypass surgery, coronary artery stenting, transient ischemic attack (TIA), cerebrovascular accident (CVA), angina, congestive heart failure, ventricular rhythm disturbances or thromboembolic disease
- Subject has a hematocrit (Hct) lower than the normal reference range
- Subject has a history of adrenal insufficiency.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method 24 hour calibration requirement 10 days Descriptive summary of sensor accuracy for Harmony 1 Sensor data with the every 24 hour calibration requirements
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie glucose sensing accuracy in Harmony 1 sensors for T1D management?
How does the Harmony 1 sensor compare to Dexcom G5 in real-time glucose monitoring for pediatric T1D patients?
What biomarkers correlate with improved sensor performance in adult T1D patients using Harmony 1 technology?
What adverse events were reported in NCT02646878 and how do they compare to Medtronic's previous glucose sensor trials?
How does the single-sample correlational design of NCT02646878 affect interpretation of Harmony 1 sensor efficacy data?